Induction of the nuclear protein 'cyclin' in quiescent mouse 3T3 cells stimulated by serum and growth factors. Correlation with DNA synthesis.

PubWeight™: 1.36‹?› | Rank: Top 10%

🔗 View Article (PMC 557835)

Published in EMBO J on December 20, 1984

Authors

R Bravo, H Macdonald-Bravo

Articles citing this

Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol (1987) 4.41

Cloning and sequence of the human nuclear protein cyclin: homology with DNA-binding proteins. Proc Natl Acad Sci U S A (1987) 3.05

Changes in the nuclear distribution of cyclin (PCNA) but not its synthesis depend on DNA replication. EMBO J (1985) 2.28

Changes in cyclin/proliferating cell nuclear antigen distribution during DNA repair synthesis. J Cell Biol (1988) 1.79

An inhibitor of the in vitro elongation reaction of simian virus 40 DNA replication is overcome by proliferating-cell nuclear antigen. Proc Natl Acad Sci U S A (1988) 1.72

A complex promoter element mediates transactivation of the human proliferating cell nuclear antigen promoter by the 243-residue adenovirus E1A oncoprotein. Mol Cell Biol (1993) 0.94

Individual nuclei in polykaryons can control cyclin distribution and DNA synthesis. EMBO J (1985) 0.93

Growth fraction in non-small cell lung cancer estimated by proliferating cell nuclear antigen and comparison with Ki-67 labeling and DNA flow cytometry data. Am J Pathol (1992) 0.88

Transcriptional coactivator cAMP response element binding protein mediates induction of the human proliferating cell nuclear antigen promoter by the adenovirus E1A oncoprotein. Proc Natl Acad Sci U S A (1997) 0.87

Radiosensitive populations and recovery in X-ray-induced apoptosis in the developing cerebellum. Acta Neuropathol (1993) 0.85

Regulation of the human proliferating cell nuclear antigen promoter by the adenovirus E1A-associated protein p107. J Virol (1998) 0.84

Inhibition of gastric cancer cell proliferation by antisense oligonucleotides targeting the messenger RNA encoding proliferating cell nuclear antigen. Br J Cancer (1994) 0.83

Molecular characterisation and stage-specific expression of proliferating cell nuclear antigen (PCNA) from the malarial parasite, Plasmodium falciparum. Nucleic Acids Res (1993) 0.83

Poor prognostic value of proliferating cell nuclear antigen labelling index in breast carcinoma. J Clin Pathol (1993) 0.82

Induction of the autoantigen proliferating cell nuclear antigen in T lymphocytes by a mycobacterial antigen. J Clin Invest (1994) 0.81

A basic cytoplasmic protein (p27) induced by serum in growth-arrested 3T3 cells but constitutively expressed in primary fibroblasts. EMBO J (1986) 0.77

Articles cited by this

High resolution two-dimensional electrophoresis of proteins. J Biol Chem (1975) 133.45

Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol (1982) 9.73

Induction of DNA synthesis in BALB/c 3T3 cells by serum components: reevaluation of the commitment process. Proc Natl Acad Sci U S A (1977) 5.20

A search for differential polypeptide synthesis throughout the cell cycle of HeLa cells. J Cell Biol (1980) 3.50

Identity of the proliferating cell nuclear antigen and cyclin. Nature (1984) 3.44

A nuclear antigen associated with cell proliferation and blast transformation. J Exp Med (1981) 2.82

Epidermal growth factor. Relationship between receptor regulation and mitogenesis in 3T3 cells. J Biol Chem (1978) 2.54

Architecture and polypeptide composition of HeLa cytoskeletons. Modification of cytoarchitectural polypeptides during mitosis. J Mol Biol (1982) 2.13

Identification of a nuclear and of a cytoplasmic polypeptide whose relative proportions are sensitive to changes in the rate of cell proliferation. Exp Cell Res (1981) 1.99

Characterization of proliferating cell nuclear antigen recognized by autoantibodies in lupus sera. J Exp Med (1984) 1.79

Cyclin: a nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells. Leuk Res (1984) 1.79

Production and characterization of mammalian cells reversibly arrested in G1 by growth in isoleucine-deficient medium. Methods Cell Biol (1973) 1.44

Gene expression in normal and virally transformed mouse 3T3b and hamster BHK21 cells. Exp Cell Res (1980) 1.24

Production and characterization of antibody blocking epidermal growth factor:receptor interactions. Biochim Biophys Acta (1980) 1.21

Coordinated synthesis of the nuclear protein cyclin and DNA in serum-stimulated quiescent 3T3 cells. FEBS Lett (1984) 1.20

Gene expression in murine hybrids exhibiting different morphologies and tumorigenic properties. Carcinogenesis (1981) 1.18

Distribution of HeLa cells polypeptides in cytoplasts and karyoplasts. Cell Biol Int Rep (1981) 1.02

Articles by these authors

Induction of c-fos gene and protein by growth factors precedes activation of c-myc. Nature (1985) 9.73

Cyclin/PCNA is the auxiliary protein of DNA polymerase-delta. Nature (1987) 8.28

Osteopetrosis in mice lacking NF-kappaB1 and NF-kappaB2. Nat Med (1997) 5.72

Complexity of the early genetic response to growth factors in mouse fibroblasts. Mol Cell Biol (1988) 5.21

Transcriptional activation of c-jun during the G0/G1 transition in mouse fibroblasts. Nature (1988) 5.04

Multiorgan inflammation and hematopoietic abnormalities in mice with a targeted disruption of RelB, a member of the NF-kappa B/Rel family. Cell (1995) 4.70

Defects in macrophage recruitment and host defense in mice lacking the CCR2 chemokine receptor. J Exp Med (1997) 4.57

Existence of two populations of cyclin/proliferating cell nuclear antigen during the cell cycle: association with DNA replication sites. J Cell Biol (1987) 4.41

The product of a novel growth factor activated gene, fos B, interacts with JUN proteins enhancing their DNA binding activity. EMBO J (1989) 4.27

Two mouse genes encoding potential transcription factors with identical DNA-binding domains are activated by growth factors in cultured cells. Proc Natl Acad Sci U S A (1988) 4.08

RelB, a new Rel family transcription activator that can interact with p50-NF-kappa B. Mol Cell Biol (1992) 4.03

A gene encoding a protein with zinc fingers is activated during G0/G1 transition in cultured cells. EMBO J (1988) 3.98

A novel mitogen-inducible gene product related to p50/p105-NF-kappa B participates in transactivation through a kappa B site. Mol Cell Biol (1992) 3.63

Characterization of junD: a new member of the jun proto-oncogene family. EMBO J (1989) 3.55

A search for differential polypeptide synthesis throughout the cell cycle of HeLa cells. J Cell Biol (1980) 3.50

c-JUN, JUN B, and JUN D differ in their binding affinities to AP-1 and CRE consensus sequences: effect of FOS proteins. Oncogene (1991) 3.41

Activation of the nuclear factor-kappaB by Rho, CDC42, and Rac-1 proteins. Genes Dev (1997) 3.23

The jun and fos protein families are both required for cell cycle progression in fibroblasts. Mol Cell Biol (1991) 3.08

Cloning and sequence of the human nuclear protein cyclin: homology with DNA-binding proteins. Proc Natl Acad Sci U S A (1987) 3.05

The leucine repeat motif in Fos protein mediates complex formation with Jun/AP-1 and is required for transformation. Cell (1989) 2.84

An enzymatic assay reveals that proteins destined for the apical or basolateral domains of an epithelial cell line share the same late Golgi compartments. EMBO J (1985) 2.78

Nuclear factor (NF)-kappa B2 (p100/p52) is required for normal splenic microarchitecture and B cell-mediated immune responses. J Exp Med (1998) 2.78

Altered gene expression in neurons during programmed cell death: identification of c-jun as necessary for neuronal apoptosis. J Cell Biol (1994) 2.75

Controlled recruitment of monocytes and macrophages to specific organs through transgenic expression of monocyte chemoattractant protein-1. J Immunol (1995) 2.47

Changes in the nuclear distribution of cyclin (PCNA) but not its synthesis depend on DNA replication. EMBO J (1985) 2.28

Rapid induction in regenerating liver of RL/IF-1 (an I kappa B that inhibits NF-kappa B, RelB-p50, and c-Rel-p50) and PHF, a novel kappa B site-binding complex. Mol Cell Biol (1992) 2.27

Disruption of the erp/mkp-1 gene does not affect mouse development: normal MAP kinase activity in ERP/MKP-1-deficient fibroblasts. Oncogene (1996) 2.20

Segment-specific expression of a zinc-finger gene in the developing nervous system of the mouse. Nature (1989) 2.18

Gastric hyperplasia and increased proliferative responses of lymphocytes in mice lacking the COOH-terminal ankyrin domain of NF-kappaB2. J Exp Med (1997) 2.13

Architecture and polypeptide composition of HeLa cytoskeletons. Modification of cytoarchitectural polypeptides during mitosis. J Mol Biol (1982) 2.13

The presence of dialkylphosphates in fresh fruit juices: implication for organophosphorus pesticide exposure and risk assessments. J Toxicol Environ Health A (2005) 2.05

Characterization of a mouse multigene family that encodes zinc finger structures. Mol Cell Biol (1988) 2.05

Identification of a nuclear and of a cytoplasmic polypeptide whose relative proportions are sensitive to changes in the rate of cell proliferation. Exp Cell Res (1981) 1.99

Structure, mapping and expression of a growth factor inducible gene encoding a putative nuclear hormonal binding receptor. EMBO J (1989) 1.98

Cloning and functional expression of mCCR2, a murine receptor for the C-C chemokines JE and FIC. J Biol Chem (1996) 1.94

The NFAT-1 DNA binding complex in activated T cells contains Fra-1 and JunB. Mol Cell Biol (1993) 1.94

Synthesis of the nuclear protein cyclin (PCNA) and its relationship with DNA replication. Exp Cell Res (1986) 1.92

Impaired macrophage function and enhanced T cell-dependent immune response in mice lacking CCR5, the mouse homologue of the major HIV-1 coreceptor. J Immunol (1998) 1.92

Expression of different Jun and Fos proteins during the G0-to-G1 transition in mouse fibroblasts: in vitro and in vivo associations. Mol Cell Biol (1991) 1.91

Involvement of common and cell type-specific pathways in c-fos gene control: stable induction of cAMP in macrophages. Cell (1987) 1.83

The immediate-early growth response in regenerating liver and insulin-stimulated H-35 cells: comparison with serum-stimulated 3T3 cells and identification of 41 novel immediate-early genes. Mol Cell Biol (1991) 1.82

Structure, mapping, and expression of fisp-12, a growth factor-inducible gene encoding a secreted cysteine-rich protein. Cell Growth Differ (1991) 1.80

Chronic inflammation and susceptibility to bacterial infections in mice lacking the polypeptide (p)105 precursor (NF-kappaB1) but expressing p50. J Exp Med (1998) 1.79

Changes in cyclin/proliferating cell nuclear antigen distribution during DNA repair synthesis. J Cell Biol (1988) 1.79

Cyclin: a nuclear protein whose level correlates directly with the proliferative state of normal as well as transformed cells. Leuk Res (1984) 1.79

Structure, chromosome location, and expression of the mouse zinc finger gene Krox-20: multiple gene products and coregulation with the proto-oncogene c-fos. Mol Cell Biol (1989) 1.78

Exocytotic pathways exist to both the apical and the basolateral cell surface of the polarized epithelial cell MDCK. Cell (1985) 1.76

Stimulation and inhibition of growth by EGF in different A431 cell clones is accompanied by the rapid induction of c-fos and c-myc proto-oncogenes. EMBO J (1985) 1.73

Up-dated catalogue of HeLa cell proteins: percentages and characteristics of the major cell polypeptides labeled with a mixture of 16 14C-labeled amino acids. Clin Chem (1982) 1.70

Existence of different Fos/Jun complexes during the G0-to-G1 transition and during exponential growth in mouse fibroblasts: differential role of Fos proteins. Mol Cell Biol (1992) 1.66

Phosphorylation changes associated with the early cell cycle in Xenopus eggs. Dev Biol (1987) 1.65

Interactions among LRF-1, JunB, c-Jun, and c-Fos define a regulatory program in the G1 phase of liver regeneration. Mol Cell Biol (1992) 1.64

Structure, mapping, and expression of erp, a growth factor-inducible gene encoding a nontransmembrane protein tyrosine phosphatase, and effect of ERP on cell growth. Mol Cell Biol (1993) 1.62

Constitutive and inducible Rel/NF-kappa B activities in mouse thymus and spleen. Oncogene (1994) 1.59

Human proteins sensitive to neoplastic transformation in cultured epithelial and fibroblast cells. Clin Chem (1982) 1.57

Putative association of mitochondria with a subpopulation of intermediate-sized filaments in cultured human skin fibroblasts. Cell (1982) 1.54

Regulation of c-fos transcription in mouse fibroblasts: identification of DNase I-hypersensitive sites and regulatory upstream sequences. EMBO J (1985) 1.51

Expression of relB transcripts during lymphoid organ development: specific expression in dendritic antigen-presenting cells. Development (1993) 1.48

Both N- and C-terminal domains of RelB are required for full transactivation: role of the N-terminal leucine zipper-like motif. Mol Cell Biol (1993) 1.46

Functional redundancy of the nuclear factor kappa B inhibitors I kappa B alpha and I kappa B beta. J Exp Med (1998) 1.45

c-Fos-induced activation of a TATA-box-containing promoter involves direct contact with TATA-box-binding protein. Mol Cell Biol (1994) 1.42

Wounding a fibroblast monolayer results in the rapid induction of the c-fos proto-oncogene. EMBO J (1986) 1.42

Expression of c-fos in NIH3T3 cells is very low but inducible throughout the cell cycle. EMBO J (1986) 1.41

B cells genetically deficient in the c-Rel transactivation domain have selective defects in germline CH transcription and Ig class switching. J Immunol (1997) 1.38

Circulating hepatitis C virus genotypes in Spain. The Hepatitis/HIV Spanish Study Group. Vox Sang (1996) 1.38

[Interrelationship between the duration of HIV infection, viral load and CD4 positive lymphocyte count]. Med Clin (Barc) (1998) 1.38

[Rapid and slow progression of the infection by the type 1 human immunodeficiency virus in a population of seropositive subjects in Madrid]. Med Clin (Barc) (1996) 1.38

Multifocal defects in immune responses in RelB-deficient mice. J Immunol (1997) 1.36

[35S]-methionine labelled polypeptides from HELA cells. Coordinates and percentage of some major polypeptides. Cell Biol Int Rep (1981) 1.34

Role of nuclear material in the early cell cycle of Xenopus embryos. Cell (1988) 1.34

B cells lacking RelB are defective in proliferative responses, but undergo normal B cell maturation to Ig secretion and Ig class switching. J Exp Med (1996) 1.34

Developmental expression of the mouse c-rel proto-oncogene in hematopoietic organs. Development (1994) 1.34

Expression of the chemokine N51/KC in the thymus and epidermis of transgenic mice results in marked infiltration of a single class of inflammatory cells. J Exp Med (1994) 1.33

Antigen-induced eosinophilic lung inflammation develops in mice deficient in chemokine eotaxin. Blood (1998) 1.33

p50-NF-kappaB complexes partially compensate for the absence of RelB: severely increased pathology in p50(-/-)relB(-/-) double-knockout mice. J Exp Med (1997) 1.32

Tissue-specific expression of c-jun and junB during organogenesis in the mouse. Development (1989) 1.29

Activation of the granulocyte-macrophage colony-stimulating factor promoter in T cells requires cooperative binding of Elf-1 and AP-1 transcription factors. Mol Cell Biol (1994) 1.28

Coexistence of three major isoactins in a single sarcoma 180 cell. Cell (1981) 1.28

Structure and mapping of the fosB gene. FosB downregulates the activity of the fosB promoter. Nucleic Acids Res (1992) 1.24

Constitutive expression of Bc1-3 in thymocytes increases the DNA binding of NF-kappaB1 (p50) homodimers in vivo. Mol Cell Biol (1996) 1.24

Gene expression in normal and virally transformed mouse 3T3b and hamster BHK21 cells. Exp Cell Res (1980) 1.24

Differential interactions of Rel-NF-kappa B complexes with I kappa B alpha determine pools of constitutive and inducible NF-kappa B activity. EMBO J (1994) 1.23

Both products of the fosB gene, FosB and its short form, FosB/SF, are transcriptional activators in fibroblasts. Mol Cell Biol (1991) 1.23

Both multiorgan inflammation and myeloid hyperplasia in RelB-deficient mice are T cell dependent. J Immunol (1996) 1.23

Specific inhibition of RelB/p52 transcriptional activity by the C-terminal domain of p100. Oncogene (1995) 1.22

The NF-kappa B family member RelB is required for innate and adaptive immunity to Toxoplasma gondii. J Immunol (1999) 1.22

Apoptosis of nur77/N10-transgenic thymocytes involves the Fas/Fas ligand pathway. Proc Natl Acad Sci U S A (1996) 1.22

Epidermal growth factor inhibits the synthesis of the nuclear protein cyclin in A431 human carcinoma cells. Proc Natl Acad Sci U S A (1984) 1.22

[35S]-methionine labelled polypeptides from secondary mouse kidney fibroblasts: coordinates and one dimensional peptide maps of some major polypeptides. Cell Biol Int Rep (1981) 1.21

Coordinated synthesis of the nuclear protein cyclin and DNA in serum-stimulated quiescent 3T3 cells. FEBS Lett (1984) 1.20

Bombesin induces c-fos and c-myc expression in quiescent Swiss 3T3 cells. Comparative study with other mitogens. Exp Cell Res (1987) 1.19

Gene expression in murine hybrids exhibiting different morphologies and tumorigenic properties. Carcinogenesis (1981) 1.18

Overexpression of RelA in transgenic mouse thymocytes: specific increase in levels of the inhibitor protein I kappa B alpha. Mol Cell Biol (1995) 1.16